Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

MicroRNA fingerprints during influenza A infection: Discovery of unique biomarkers for diagnosis and prognosis of pandemic influenza infection in humans.

FY 2009-10

Summary
MicroRNAs are natural RNA interference molecules that are now known to regulate genes involved in a vast array of biological processes, including human viral disease. These molecules and their discovery have revolutionized both basic biomedical research and drug discovery. The importance of microRNA in modern biology is underlined by this year's recipient of the prestigious Dickson Prize in Medicine, Dr. Victor Ambros who discovered, 16 years ago, the first microRNA in the C. elegans animal model. As of this year, 11 of the Dickson Prize recipients have gone to win the Nobel Prize. MicroRNA expression within host cells has been investigated for a number of viruses and furthered our understanding of the pathogenesis of viruses such as Hepatitis C, Human Immunodeficiency Virus (HIV) and the coronavirus associated with Severe Acute Respiratory Syndrome (SARS). With the current H1N1 (swine flu) pandemic and potential still for a deadly H5N1 (bird flu) pandemic, better understanding of the cellular changes associated with pandemic influenza A (infA) infection is critical. There is no doubt that the results of our proposed exciting study on the role of human microRNAs in pandemic infA infection will be ground-breaking at several levels by providing (i) novel insights into infA biology, (ii) identifying novel biomarkers of pandemic infA viruses, and (iii) discovering desperately needed novel antiviral targets - in particular with the recent emergence of drug-resistant pandemic infA viruses.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
199619
Name
Hrabowych Alexandra A
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Canada Graduate Scholarships Master's Awards A
Projecttitle
MicroRNA fingerprints during influenza A infection: Discovery of unique biomarkers for diagnosis and prognosis of pandemic influenza infection in humans.
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Biomarkers; Confocal Microscopy; Diagnostics; Host-Virus Interactions; Influenza A Virus; Mammalian Cell Tissue Culturing; Microfluidic Chip Technology; Microrna; Pandemic Influenza A (H1n1); Real Time-Pcr
Abstract
MicroRNAs are natural RNA interference molecules that are now known to regulate genes involved in a vast array of biological processes, including human viral disease. These molecules and their discovery have revolutionized both basic biomedical research and drug discovery. The importance of microRNA in modern biology is underlined by this year's recipient of the prestigious Dickson Prize in Medicine, Dr. Victor Ambros who discovered, 16 years ago, the first microRNA in the C. elegans animal model. As of this year, 11 of the Dickson Prize recipients have gone to win the Nobel Prize. MicroRNA expression within host cells has been investigated for a number of viruses and furthered our understanding of the pathogenesis of viruses such as Hepatitis C, Human Immunodeficiency Virus (HIV) and the coronavirus associated with Severe Acute Respiratory Syndrome (SARS). With the current H1N1 (swine flu) pandemic and potential still for a deadly H5N1 (bird flu) pandemic, better understanding of the cellular changes associated with pandemic influenza A (infA) infection is critical. There is no doubt that the results of our proposed exciting study on the role of human microRNAs in pandemic infA infection will be ground-breaking at several levels by providing (i) novel insights into infA biology, (ii) identifying novel biomarkers of pandemic infA viruses, and (iii) discovering desperately needed novel antiviral targets - in particular with the recent emergence of drug-resistant pandemic infA viruses.
Competitiondate
201002
Approvedterm2
1 yr 0 mth
Pinamesdelim
Hrabowych, Alexandra A
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~